Wrist vs. groin approach for liver cancer chemoembolization
Part of Cancer, Digestive system clinical trials.
This trial compares two ways to deliver chemoembolization (a treatment that blocks the blood supply to liver cancer and delivers chemotherapy directly) — through an artery in the wrist (radial) versus the groin (femoral). It may be an option if you have a certain stage of liver cancer and are not eligible for other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cancer at BCLC stage B, or stage A if ablation is not possible.
- The goal is to shrink the tumor before surgery or transplant.
- You must not have severe liver cirrhosis symptoms like jaundice, confusion, or hard-to-treat fluid buildup.
- You must not have a blood clot in the main liver vein or cancer spread outside the liver.
- Your kidneys must work well (creatinine less than 2 mg/dL or not on dialysis).
- Your arm arteries must be healthy enough for the radial approach (e.g., no prior surgery, infection, or small artery size).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a targeted radiation treatment (radioembolization) for liver cancer that has grown into the main vein (portal vein) but is still limited to one lobe of the liver. It is for people who have not received any prior cancer treatment and whose liver function is still fairly good.
This study compares two chemotherapy drugs (raltitrexed and 5-fluorouracil) given directly into the liver's main artery to treat liver cancer. It aims to see which drug works better and is safer for people with hepatocellular carcinoma.
This trial tests combining radiation therapy (radioembolization) with surgery to remove part of the liver for people with a single large liver tumor (over 8 cm) that hasn't spread. The goal is to see if this approach can treat the tumor effectively.
This trial compares two treatments for people with large liver tumors. One is a liver artery chemotherapy infusion and the other is a chemo-embolization procedure. The study will see which approach works better.
This trial tests giving chemotherapy directly into the liver artery (HAIC) mixed with a special oil called lipiodol. It may help people with advanced liver cancer that cannot be treated with standard methods or who cannot tolerate them.
This trial tests a treatment called radioembolization for small liver cancers. Radioembolization delivers tiny radioactive beads to the tumor, and the goal is to see if it helps shrink or control the cancer.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.